Literature DB >> 17690110

Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells.

Wai Kei Kwok1, Ming-Tat Ling, Hiu Fung Yuen, Yong-Chuan Wong, Xianghong Wang.   

Abstract

Recently, TWIST, a basic helix-loop-helix transcription factor, is suggested to be an oncogene because of its over-expression in many types of human cancer and its positive role in promoting cell survival. The aim of this study was to investigate the role of TWIST on the growth of human epithelial cells. Using two immortalized human prostate epithelial cell lines, we demonstrated that inactivation of TWIST by small RNA technology led to the promotion of cellular senescence and growth arrest, suggesting that TWIST plays a key role in the continuous proliferation of immortalized cells. Over-expression of TWIST, in contrast, resulted in suppression of cellular senescence in response to genotoxic damage and promotion of cell proliferation with DNA damage accumulation, indicating that TWIST promotes genomic instability. In addition, we also found that the TWIST-mediated cellular senescence was regulated through its negative effect on p14(ARF) and subsequent suppression of MDM2/p53 and Chk1/2 DNA damage response pathways. Our results suggest that over-expression of TWIST results in down-regulation of p14(ARF), which leads to the impairment of DNA damage checkpoint in response to genotoxic stress. This negative effect of TWIST on DNA damage response facilitates uncontrolled cell proliferation with genomic instability and tumorigenesis in non-malignant cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690110     DOI: 10.1093/carcin/bgm185

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  26 in total

1.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.

Authors:  Shinya Ohashi; Mitsuteru Natsuizaka; Gabrielle S Wong; Carmen Z Michaylira; Katharine D Grugan; Douglas B Stairs; Jiri Kalabis; Maria E Vega; Ross A Kalman; Momo Nakagawa; Andres J Klein-Szanto; Meenhard Herlyn; J Alan Diehl; Anil K Rustgi; Hiroshi Nakagawa
Journal:  Cancer Res       Date:  2010-04-27       Impact factor: 12.701

2.  Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells.

Authors:  Kyoung Eun Lee; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

Review 3.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

4.  Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer.

Authors:  Tian Wang; Yan Li; Abidan Tuerhanjiang; Wenwen Wang; Zhangying Wu; Ming Yuan; Shixuan Wang
Journal:  Front Med       Date:  2014-01-08       Impact factor: 4.592

Review 5.  Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?

Authors:  Corinne Abbadie; Olivier Pluquet; Albin Pourtier
Journal:  Cell Mol Life Sci       Date:  2017-07-13       Impact factor: 9.261

6.  Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells.

Authors:  Dimitrios Cakouros; Sandra Isenmann; Lachlan Cooper; Andrew Zannettino; Peter Anderson; Carlotta Glackin; Stan Gronthos
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

7.  Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths.

Authors:  Marjon A Smit; Daniel S Peeper
Journal:  Aging (Albany NY)       Date:  2010-10       Impact factor: 5.682

8.  Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Authors:  Rute B Marques; Natasja F Dits; Sigrun Erkens-Schulze; Wytske M van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 9.  Twist: a molecular target in cancer therapeutics.

Authors:  Md Asaduzzaman Khan; Han-chun Chen; Dianzheng Zhang; Junjiang Fu
Journal:  Tumour Biol       Date:  2013-07-20

Review 10.  The role of TWIST1 in epithelial-mesenchymal transition and cancers.

Authors:  Qing-Qing Zhu; Chenhui Ma; Qian Wang; Yong Song; Tangfeng Lv
Journal:  Tumour Biol       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.